• Board of Directors

    Board of Directors

    Board of Directors

    The board of directors at
    Apollo Endosurgery Inc.

  • Board of Directors





    Board of Directors

    The board of directors at Apollo Endosurgery Inc.


Rich Meelia

Chairman of the Board

Mr. Meelia has served as the Chairman of the board of directors of Apollo since 2012. From July 2007 until his retirement in July 2011, Mr. Meelia served as Chairman, President, and Chief Executive Officer of Covidien plc following its separation from Tyco International in June 2007. From January 2006 through the separation, Mr. Meelia was the Chief Executive Officer of Tyco Healthcare and from 1995 through the separation, Mr. Meelia was also the President of Tyco Healthcare. Mr. Meelia joined Kendall Healthcare Products Company, the foundation of both the Tyco Healthcare Business and Covidien, as Group President in 1991. Mr. Meelia is a member of the board of directors of Haemonetics Corporation, for which he serves as Chairman, and ConformMIS, Inc. Mr. Meelia holds a B.A business from Saint Anselm College and an M.B.A. from Boston College.

Todd Newton

Chief Executive Officer, Director

Mr. Newton has served as Chief Executive Officer and as a member of the board of directors of Apollo since 2014. From 2009 to 2014, Mr. Newton served as Executive Vice President, Chief Financial Officer and Chief Operating Officer at ArthroCare Corporation, a medical device company. Prior to his leadership at ArthroCare, Mr. Newton served in a number of executive officer roles, including President and Chief Executive Officer, at Synenco Energy, Inc., a Canadian oilsands company. From 1994 to 2004, Mr. Newton was a Partner at Deloitte & Touche LLP. Mr. Newton holds a B.B.A. in accounting from The University of Texas at San Antonio..

Matthew S. Crawford

Director

Mr. Crawford has served as a member of the board of directors of Apollo since 2006. In 2003, Mr. Crawford founded PTV Healthcare Capital, a venture capital and private equity firm specializing in the healthcare and life sciences industries, and has served ever since as Founding Managing Director. Matt has spent his 30 year career in the private equity, venture capital, banking and finance industries. He has served on more than 20 healthcare company boards of directors and currently serves on the boards of directors of several private companies. Matt is an Executive Committee member for The University of Texas Chancellor’s Council, as well as an active member of the Children’s Council for the Dell Children’s Medical Center Foundation. Most recently, Matt was appointed to the Wake Forest Board of Trustees. Matt holds a B.A. in History and an M.B.A. from Wake Forest University.

David C. Pacitti

Director

Mr. Pacitti has served as a member of the board of directors of Apollo since 2017. Mr. Pacitti is currently the President and CEO of Siemens Medical Solutions, North America and Head of North America-Siemens Healthineers where he has responsibility for Siemen’s multi-billion dollar commercial operation in the United States. Prior to his role at Siemens, Mr. Pacitti was with Abbott Vascular in a variety of commercial leadership roles. Mr. Pacitti is a graduate of Villanova University and serves on the board of directors of the Advanced Medical Technology Association (AdvaMed).

Bruce Robertson, Ph.D.

Director

Dr. Robertson has served as a member of the board of directors of Apollo since 2007. Since 2005, Dr. Robertson has served as Managing Director of H.I.G. Capital, LLC, a global private equity and investment firm. From 2003 to 2005, Dr. Robertson served as Managing Director at Toucan Capital, an early-stage venture capital fund focusing on life science investments. Dr. Robertson holds a B.S.E. in chemical engineering and B.A. in mathematics from the University of Pennsylvania, an M.B.A. from Harvard Business School, and a Ph.D. in chemical engineering from the University of Delaware.

R. Kent McGaughy, Jr.

Director

Mr. McGaughy has served as a member of the board of directors of Apollo since 2012. Since 2003, Mr. McGaughy has served as a Managing Director at CPMG, Inc. where he is a founding shareholder. Prior to joining CPMG’s predecessor, Cardinal Investment Company, in 1997, Mr. McGaughy worked in investment banking at Simmons & Company International. Mr. McGaughy is a member of the board of directors of one publicly listed company, Reata Pharmaceuticals Inc. and is a member of the board of directors of several private companies. He formerly served as a Director of Mandiant Corporation. He holds a B.A. in Plan II (summa cum laude and member of Phi Beta Kappa) from The University of Texas and an M.B.A. from Harvard Business School.

Rick Anderson

Director

Mr. Anderson has served as a member of the board of directors of Apollo since 2013. Since 2008, Mr. Anderson has served as a Managing Director at PTV Healthcare Capital, a venture capital and private equity firm specializing in the healthcare and life sciences industries. Prior to PTV, Mr. Anderson was a medical device executive in a number of senior roles at Johnson & Johnson including Company Group Chairman and Worldwide Franchise Chairman of Cordis Corporation (2005 – 2007) and President of Cordis Corporation (2003 – 2005). Mr. Anderson is the Chairman of the Board for Cardiva Medical, and is an Independent Director on the Board of ConvaTec PLC, a FTSI 100 company. Mr. Anderson holds a B.B.A. in marketing from Mississippi State University. He served five years in the U.S. Army where he obtained the rank of captain.

Bill McClellan

Director

Mr. McClellan has served as a member of the board of directors of Apollo since 2014. Mr. McClellan has served as the Chief Financial Officer at Aerin Medical Inc. since January 2018. From June 2004 until June 2016, Mr. McClellan was the Chief Financial Officer and Executive Vice President, Finance at On-X Life Technologies Holdings, Inc. Prior to June 2004, Mr. McClellan held financial and accounting positions at various companies and was an auditor with Price Waterhouse Coopers for nine years. He currently serves on the board of directors of Reata Pharmaceuticals, Inc., a publicly-traded company, and chairs its audit committee. Mr. McClellan, Jr. received a B.B.A. in accounting from Abilene Christian University and is a certified public accountant.

Julie Shimer

Director

Dr. Shimer has served as a member of the board of directors of Apollo since 2018. Dr. Shimer is currently a private investor and has 30 years of product development experience, including many years with major communications companies. From March 2007 to April 2012 she served as Chief Executive Officer of Welch Allyn, Inc., a manufacturer of frontline medical products and solutions, having served on the board of directors beginning in July 2002. Prior to her role at Welch Allyn, Dr. Shimer was President and Chief Executive Officer of Vocera Communications, Inc., a provider of wireless communications systems, also serving on the board of directors. She also has served as general manager at 3Com Corporation and Motorola and has been a product development leader at Motorola and AT&T Bell Laboratories. Dr. Shimer is a graduate of Rensselaer Polytechnic Institute (B.S. Physics) and Lehigh University (M.S., Ph.D. in Electrical Engineering). She serves on the board of directors of Netgear, Halyard Health, and Windstream as well as three non-profit organizations.